Cypre
Organoid
Platform

Human-derived tumor microenvironment organoids (TMOs) integrating immune and stromal compartments — built for MOA insights.

Tumor-stroma-immune in the Cypre Organoid Platform

Our platform enables:

Immune-and-stromal-integrated mechanism of action (MOA) analysis
Cytokine and functional immune profiling
Multi-omic readouts to support biomarker discovery
Application across bispecifics, IO agents, and tumor-specific assets

We partner with leading biopharmaceuticals to discover and develop the next generation of cancer immunotherapies.